A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...

Moderna previously reported a summary of the results from the company-sponsored trial in 8,000 people. The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved ...